MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4&...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717574/?tool=EBI |
id |
doaj-2f3e1d72868c4fb8b1ba01aef2939cba |
---|---|
record_format |
Article |
spelling |
doaj-2f3e1d72868c4fb8b1ba01aef2939cba2021-03-03T23:19:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6423510.1371/journal.pone.0064235MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.Chan XieJueheng WuJingping YunJiaming LaiYunfei YuanZhiliang GaoMengfeng LiJun LiLibing Song<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4>Methods</h4>mRNA and protein levels of MACC1 expression in one normal liver epithelial cells THLE3 and 15 HCC cell lines were examined using reverse transcription-PCR and Western blot. MACC1 expression was also comparatively studied in 6 paired HCC lesions and the adjacent non-cancerous tissue samples. Immunohistochemistry was employed to analyze MACC1 expression in 308 clinicopathologically characterized HCC cases. Statistical analyses were applied to derive association between MACC1 expression scores and clinical staging as well as patient survival.<h4>Results</h4>Levels of MACC1 mRNA and protein were higher in HCC cell lines and HCC lesions than in normal liver epithelial cells and the paired adjacent noncancerous tissues. Significant difference in MACC1 expression was found in patients of different TNM stages (P<0.001). Overall survival analysis showed that high MACC1 expression level correlated with lower survival rate (P = 0.001). Importantly, an inverse correlation between MACC1 level and patient survival remained significant in subjects with early-stage HCC or with normal serum AFP level.<h4>Conclusions</h4>MACC1 protein may represent a promising biomarker for predicting the prognosis of HCC, including in early-stage and AFP-normal patients.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717574/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chan Xie Jueheng Wu Jingping Yun Jiaming Lai Yunfei Yuan Zhiliang Gao Mengfeng Li Jun Li Libing Song |
spellingShingle |
Chan Xie Jueheng Wu Jingping Yun Jiaming Lai Yunfei Yuan Zhiliang Gao Mengfeng Li Jun Li Libing Song MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS ONE |
author_facet |
Chan Xie Jueheng Wu Jingping Yun Jiaming Lai Yunfei Yuan Zhiliang Gao Mengfeng Li Jun Li Libing Song |
author_sort |
Chan Xie |
title |
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. |
title_short |
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. |
title_full |
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. |
title_fullStr |
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. |
title_full_unstemmed |
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. |
title_sort |
macc1 as a prognostic biomarker for early-stage and afp-normal hepatocellular carcinoma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4>Methods</h4>mRNA and protein levels of MACC1 expression in one normal liver epithelial cells THLE3 and 15 HCC cell lines were examined using reverse transcription-PCR and Western blot. MACC1 expression was also comparatively studied in 6 paired HCC lesions and the adjacent non-cancerous tissue samples. Immunohistochemistry was employed to analyze MACC1 expression in 308 clinicopathologically characterized HCC cases. Statistical analyses were applied to derive association between MACC1 expression scores and clinical staging as well as patient survival.<h4>Results</h4>Levels of MACC1 mRNA and protein were higher in HCC cell lines and HCC lesions than in normal liver epithelial cells and the paired adjacent noncancerous tissues. Significant difference in MACC1 expression was found in patients of different TNM stages (P<0.001). Overall survival analysis showed that high MACC1 expression level correlated with lower survival rate (P = 0.001). Importantly, an inverse correlation between MACC1 level and patient survival remained significant in subjects with early-stage HCC or with normal serum AFP level.<h4>Conclusions</h4>MACC1 protein may represent a promising biomarker for predicting the prognosis of HCC, including in early-stage and AFP-normal patients. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717574/?tool=EBI |
work_keys_str_mv |
AT chanxie macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT juehengwu macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT jingpingyun macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT jiaminglai macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT yunfeiyuan macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT zhilianggao macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT mengfengli macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT junli macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma AT libingsong macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma |
_version_ |
1714811622649757696 |